Watson biology: 13 valent pneumococcal polysaccharide conjugate vaccine has been licensed in Morocco
Watson biology announced that Yuxi Watson, the holding subsidiary of the company, recently received the marketing license of 13 valent pneumococcal polysaccharide conjugate vaccine issued by the Ministry of health and social security of Morocco, marking that Yuxi Watson 13 valent pneumonia conjugate vaccine has been registered in Morocco and can be officially exported to Morocco.
This text is a result of machine translation.
Related companies：
In-depth
Technology
DeepSeek | China's AI Global Breakthrough and Ecosystem Restructuring
Mar 19, 2025 01:18 PM
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Dec 12, 2021 05:48 PM
· Healthcare
Watson biology: Yuxi Watson plans to invest in the production and capacity expansion project of polysaccharide conjugate vaccine, with a total investment of 695 million yuan
Technology
EqualOcean and CCDIBC Sign Strategic Cooperation Agreement
On April 14, 2025, Beijing EO Technology Co.,Ltd (hereinafter referred to as "EqualOcean"), officially signed a strategic cooperation agreement with the Câmara de Comércio de Desenvolvimento Internacional Brasil-China (CCDIBC).
Yesterday 06:04 PM
Briefing Sep 02, 2021 02:06 PM
· Healthcare
Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%
Briefing Jul 29, 2021 10:01 AM
Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%
See more
Read next
Insight
In-depth
Insight
In-depth
Automotive · Analysis
$30 Million Lost Annually in the West, Yet Chinese Enterprises Pay No Attention
Apr 30, 2025 11:14 AM
Insight
In-depth
Technology · Analysis
Auto Shanghai 2025 - Nullmax Showcases Full-Stack Automated Driving Solutions
Apr 25, 2025 11:24 PM
Insight
In-depth
Technology · Analysis
SAIC MAXUS Partners with Huawei Qiankun, Multiple Models to be Launched
Apr 25, 2025 08:41 PM